Incomplete Kawasaki Disease: Evaluation and Management
In a child under five years with fever lasting five days and only two to three principal Kawasaki disease features, you must immediately obtain inflammatory markers (ESR and CRP), and if either ESR ≥40 mm/hr or CRP ≥3.0 mg/dL, proceed with complete laboratory evaluation and urgent echocardiography—then treat with IVIG 2 g/kg plus high-dose aspirin if three or more supplementary laboratory findings are present or if echocardiography shows coronary abnormalities. 1
Diagnostic Criteria and Clinical Recognition
Incomplete Kawasaki disease refers to patients with fever ≥5 days who have only 2-3 of the five principal clinical features, not patients with atypical presentations. 1 The five principal features are:
- Bilateral non-purulent conjunctival injection (bulbar, sparing the limbus)
- Oral mucosal changes (cracked lips, strawberry tongue, diffuse erythema)
- Polymorphous rash (maculopapular, erythrodermic, or erythema multiforme-like)
- Extremity changes (erythema/edema of hands/feet with sharp demarcation)
- Cervical lymphadenopathy ≥1.5 cm diameter 1
Incomplete Kawasaki disease is significantly more common in infants under one year and paradoxically carries a higher risk of coronary artery aneurysms if untreated, making timely recognition in this age group absolutely critical. 1
Algorithmic Evaluation Approach
Step 1: Initial Laboratory Assessment
When a child has fever ≥5 days with 2-3 principal features, immediately measure:
- ESR and CRP as the initial screening tests 1
If ESR <40 mm/hr AND CRP <3.0 mg/dL: Perform serial clinical and laboratory re-evaluation if fever persists. 1
If ESR ≥40 mm/hr OR CRP ≥3.0 mg/dL: Proceed immediately to Step 2. 1
Step 2: Comprehensive Laboratory Evaluation
Obtain the following supplementary laboratory tests:
- Anemia for age
- Platelet count ≥450,000/mm³ after the 7th day of fever
- Albumin <3.0 g/dL
- Elevated ALT level
- WBC count ≥15,000/mm³
- Urine ≥10 WBC/high-power field 1
Step 3: Echocardiography
Perform urgent echocardiography looking for:
- Coronary artery Z-scores ≥2.5 for LAD or RCA (highly specific for diagnosis)
- Perivascular brightness, ectasia, lack of tapering (early arteritis signs)
- Decreased left ventricular contractility
- Mild valvular regurgitation (especially mitral)
- Pericardial effusion 1
Step 4: Treatment Decision
Treat with IVIG if:
- Three or more of the supplementary laboratory findings are present, OR
- Echocardiography shows coronary artery abnormalities (Z-score ≥2.5) 1
Special Considerations for Infants <6 Months
For any infant aged ≤6 months with fever ≥7 days, laboratory evidence of systemic inflammation, and no other explanation for the febrile illness, obtain echocardiography even if no principal clinical features are present. 1 These infants may present with fever and irritability as the sole manifestations yet remain at substantial risk for coronary abnormalities. 1
Treatment Protocol
Once incomplete Kawasaki disease is diagnosed:
Initial therapy:
- IVIG 2 g/kg as a single infusion over 10-12 hours
- High-dose aspirin 80-100 mg/kg/day divided into four doses 2
Timing is critical: Initiate treatment within 10 days of fever onset to reduce coronary artery abnormality risk from 15-25% down to approximately 5%. 1, 2 However, children presenting after day 10 should still receive IVIG if they have ongoing fever, elevated inflammatory markers, or coronary abnormalities. 2
Continue high-dose aspirin until the patient has been afebrile for 48-72 hours, then transition to low-dose aspirin 3-5 mg/kg/day once daily. 2
Common Diagnostic Pitfalls to Avoid
Do not dismiss incomplete Kawasaki disease because:
- The child lacks conjunctivitis or other "classic" features—incomplete presentations are the norm in young infants 1
- Rash and mucosal changes are attributed to antibiotic reaction after treatment for presumed bacterial lymphadenitis—this is a classic missed diagnosis scenario 1
- Sterile pyuria is mistaken for partially treated urinary tract infection 1
- Fever with irritability and CSF pleocytosis is diagnosed as viral meningitis 1
Do not wait for all five principal criteria in children under one year with prolonged fever—incomplete Kawasaki disease is more common in this age group and carries the same coronary complication risk. 1
Monitoring After Treatment
Use CRP rather than ESR to monitor inflammation after IVIG therapy, as IVIG artificially elevates ESR. 1, 2
Perform echocardiography at:
- Diagnosis
- 2 weeks after treatment
- 6-8 weeks after treatment 2
Continue low-dose aspirin for 6-8 weeks if no coronary abnormalities develop; if coronary abnormalities are present, aspirin may be continued indefinitely with additional antiplatelet or anticoagulation therapy depending on aneurysm size. 2